A detailed history of Fred Alger Management, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Fred Alger Management, LLC holds 651,399 shares of TECH stock, worth $47.8 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
651,399
Previous 837,799 22.25%
Holding current value
$47.8 Million
Previous $60 Million 13.29%
% of portfolio
0.26%
Previous 0.3%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$70.96 - $82.35 $13.2 Million - $15.4 Million
-186,400 Reduced 22.25%
651,399 $52.1 Million
Q2 2024

Aug 14, 2024

BUY
$62.12 - $84.15 $1.22 Million - $1.66 Million
19,675 Added 2.4%
837,799 $60 Million
Q1 2024

May 15, 2024

SELL
$65.98 - $77.09 $7.52 Million - $8.79 Million
-113,972 Reduced 12.23%
818,124 $57.6 Million
Q4 2023

Feb 14, 2024

SELL
$52.83 - $78.22 $1.27 Million - $1.88 Million
-23,982 Reduced 2.51%
932,096 $71.9 Million
Q3 2023

Nov 14, 2023

SELL
$67.52 - $89.42 $12 Million - $15.9 Million
-178,004 Reduced 15.7%
956,078 $65.1 Million
Q2 2023

Aug 14, 2023

SELL
$73.76 - $85.98 $219,583 - $255,962
-2,977 Reduced 0.26%
1,134,082 $92.6 Million
Q1 2023

May 15, 2023

SELL
$71.62 - $86.62 $14.3 Million - $17.3 Million
-200,132 Reduced 14.97%
1,137,059 $84.4 Million
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $72 Million - $314 Million
892,681 Added 200.82%
1,337,191 $111 Million
Q3 2022

Nov 14, 2022

SELL
$282.54 - $391.85 $16.2 Million - $22.4 Million
-57,268 Reduced 11.41%
444,510 $126 Million
Q2 2022

Aug 15, 2022

SELL
$322.67 - $449.65 $105 Million - $146 Million
-325,649 Reduced 39.36%
501,778 $174 Million
Q1 2022

May 16, 2022

SELL
$353.85 - $487.79 $47.5 Million - $65.4 Million
-134,106 Reduced 13.95%
827,427 $358 Million
Q4 2021

Feb 14, 2022

BUY
$456.15 - $525.06 $5.44 Million - $6.27 Million
11,932 Added 1.26%
961,533 $497 Million
Q3 2021

Nov 15, 2021

SELL
$444.87 - $538.88 $3.05 Million - $3.7 Million
-6,866 Reduced 0.72%
949,601 $460 Million
Q2 2021

Aug 16, 2021

BUY
$387.35 - $450.26 $48.6 Million - $56.4 Million
125,346 Added 15.08%
956,467 $431 Million
Q1 2021

May 17, 2021

SELL
$314.62 - $411.0 $6.19 Million - $8.09 Million
-19,674 Reduced 2.31%
831,121 $317 Million
Q4 2020

Feb 16, 2021

BUY
$246.9 - $321.87 $14.8 Million - $19.3 Million
59,954 Added 7.58%
850,795 $270 Million
Q3 2020

Nov 13, 2020

BUY
$232.22 - $282.96 $10.4 Million - $12.7 Million
44,906 Added 6.02%
790,841 $196 Million
Q2 2020

Aug 14, 2020

BUY
$185.43 - $279.56 $4.47 Million - $6.75 Million
24,132 Added 3.34%
745,935 $197 Million
Q1 2020

May 15, 2020

SELL
$161.17 - $221.51 $13.3 Million - $18.3 Million
-82,547 Reduced 10.26%
721,803 $137 Million
Q4 2019

Feb 14, 2020

SELL
$189.68 - $222.09 $2.04 Million - $2.39 Million
-10,777 Reduced 1.32%
804,350 $177 Million
Q3 2019

Nov 14, 2019

BUY
$183.56 - $216.72 $17.7 Million - $21 Million
96,685 Added 13.46%
815,127 $159 Million
Q2 2019

Aug 14, 2019

SELL
$188.72 - $215.43 $8.26 Million - $9.43 Million
-43,758 Reduced 5.74%
718,442 $150 Million
Q1 2019

May 14, 2019

SELL
$136.09 - $200.44 $6.97 Million - $10.3 Million
-51,236 Reduced 6.3%
762,200 $151 Million
Q4 2018

Feb 14, 2019

BUY
$132.75 - $203.8 $16.4 Million - $25.1 Million
123,255 Added 17.86%
813,436 $118 Million
Q3 2018

Nov 14, 2018

BUY
$147.44 - $204.11 $28.2 Million - $39 Million
191,221 Added 38.32%
690,181 $141 Million
Q2 2018

Jul 19, 2018

BUY
$144.9 - $165.58 $18.2 Million - $20.8 Million
125,819 Added 33.72%
498,960 $73.8 Million
Q1 2018

May 10, 2018

BUY
$131.46 - $151.04 $4.64 Million - $5.33 Million
35,263 Added 10.44%
373,141 $56.4 Million
Q4 2017

Feb 14, 2018

BUY
$121.17 - $134.75 $1.8 Million - $2 Million
14,843 Added 4.59%
337,878 $43.8 Million
Q3 2017

Nov 14, 2017

BUY
$113.59 - $123.78 $36.7 Million - $40 Million
323,035
323,035 $39.1 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.88B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.